Viaskin Pertussis Vaccine Trial

NCT03035370 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

102

Enrollment

INDUSTRY

Sponsor class

Conditions

Whooping Cough

Interventions

BIOLOGICAL: Viaskin PT 25 mcg
BIOLOGICAL: Viaskin PT 50 mcg
BIOLOGICAL: Viaskin PT Placebo
BIOLOGICAL: Boostrix™

Sponsor

DBV Technologies

Collaborators

[object Object]